UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The breast tissue microbiome, stroma, immune cells and breast cancer

Neoplasia (New York, N.Y.), 2022-05, Vol.27, p.100786-100786, Article 100786

2022

Volltextzugriff (PDF)

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

Journal of clinical oncology, 2011-12, Vol.29 (34), p.4491-4497

2011

Volltextzugriff (PDF)

Update on Immunohistochemical Analysis in Breast Lesions

Archives of pathology & laboratory medicine (1976), 2017-08, Vol.141 (8), p.1033-1051

2017

Volltextzugriff (PDF)

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2115-2122

2013

Volltextzugriff (PDF)

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

JNCI : Journal of the National Cancer Institute, 2012-01, Vol.104 (2), p.159-162

2012

Volltextzugriff (PDF)

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)

Breast cancer research and treatment, 2013-02, Vol.138 (1), p.99-108

2013

Volltextzugriff (PDF)

Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas

American journal of clinical pathology, 2005-04, Vol.123 (4), p.541-546

2005

Volltextzugriff (PDF)

Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disorders

Modern pathology, 2013-02, Vol.26 (2), p.232-238

2013

Volltextzugriff (PDF)

Image Analysis of HER2 Immunohistochemical Staining: Reproducibility and Concordance With Fluorescence In Situ Hybridization of a Laboratory-Validated Scoring Technique

American journal of clinical pathology, 2012-02, Vol.137 (2), p.270-276

2012

Volltextzugriff (PDF)

Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer

Breast cancer research : BCR, 2012-05, Vol.14 (3), p.R75-R75, Article R75

2012

Volltextzugriff (PDF)

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

Human pathology, 2010, Vol.41 (1), p.103-106

2010

Volltextzugriff (PDF)

Papillary Thyroid Carcinoma BPAF Immunopositivity

Mayo Clinic proceedings, 2021-01, Vol.96 (1), p.267

2021

Volltextzugriff (PDF)

HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: A single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring

American journal of clinical pathology, 2004-05, Vol.121 (5), p.631-636

2004

Volltextzugriff (PDF)

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

Clinical cancer research, 2013-10, Vol.19 (20), p.5798-5807

2013

Volltextzugriff (PDF)

Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study

Modern pathology, 2005-10, Vol.18 (10), p.1350-1356

2005

Volltextzugriff (PDF)

C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Journal of clinical oncology, 2011-02, Vol.29 (6), p.651-659

2011

Volltextzugriff (PDF)

Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: Does it measure up to fluorescence in situ hybridization?

American journal of clinical pathology, 2005-02, Vol.123 (2), p.237-243

2005

Volltextzugriff (PDF)

Her-2/neu and topoisomerase IIα gene amplification and protein expression in invasive breast carcinomas : Chromogenic in situ hybridization and immunohistochemical analyses

American journal of clinical pathology, 2005-06, Vol.123 (6), p.889-895

2005

Volltextzugriff (PDF)

Intramammary lymph nodes: Patterns of discovery and clinical significance

Surgery, 2009-05, Vol.145 (5), p.495-499

2009

Volltextzugriff (PDF)

Anastomosing Hemangioma

Mayo Clinic proceedings, 2022-09, Vol.97 (9), p.1756-1757

2022

Volltextzugriff (PDF)

Metaplastic Breast Cancer

Mayo Clinic proceedings, 2021-09, Vol.96 (9), p.2498-2499

2021

Volltextzugriff (PDF)

Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2282-2290

2011

Volltextzugriff (PDF)

Desmoid Tumor and Multiple Colon Adenomas

Mayo Clinic proceedings, 2022-01, Vol.97 (1), p.193-195

2022

Volltextzugriff (PDF)

Juvenile Papillomatosis of Breast

Mayo Clinic proceedings, 2021-04, Vol.96 (4), p.1097-1098

2021

Volltextzugriff (PDF)

Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma

Human pathology, 2002-10, Vol.33 (10), p.968-974

2002

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(124)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(78)
Humans
(64)
Female
(49)
Breast Cancer
(39)
Pathology
(33)
Middle Aged
(30)
Immunohistochemistry
(29)
Adult
(27)
Biological And Medical Sciences
(27)
Oncology
(25)
Tumors
(25)
Breast Neoplasms - Pathology
(24)
Aged
(22)
Medical Sciences
(21)
In Situ Hybridization, Fluorescence
(18)
Breast Neoplasms - Genetics
(17)
Breast Neoplasms - Drug Therapy
(15)
Gene Amplification
(15)
Receptor, Erbb-2 - Genetics
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The breast tissue microbiome, stroma, immune cells and breast cancer

Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer

Update on Immunohistochemical Analysis in Breast Lesions

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)

Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast carcinomas

Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disorders

Image Analysis of HER2 Immunohistochemical Staining: Reproducibility and Concordance With Fluorescence In Situ Hybridization of a Laboratory-Validated Scoring Technique

Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

Papillary Thyroid Carcinoma BPAF Immunopositivity

HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: A single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study

C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: Does it measure up to fluorescence in situ hybridization?

Her-2/neu and topoisomerase IIα gene amplification and protein expression in invasive breast carcinomas : Chromogenic in situ hybridization and immunohistochemical analyses

Intramammary lymph nodes: Patterns of discovery and clinical significance

Anastomosing Hemangioma

Metaplastic Breast Cancer

Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues

Desmoid Tumor and Multiple Colon Adenomas

Juvenile Papillomatosis of Breast

Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma

Suchergebnisse filtern